[1] 邢杨波, 郭航远, 徐超,等. 阵发性心房颤动射频消融术后空白期口服胺碘酮对血浆MMP-2与TIMP-2的影响及与远期复发的关系[J].中国循环杂志, 2016, 31(s1):48.
[2] 王晓雅, 徐燕爽, 叶卉. 持续性房颤患者射频消融术中体表心电图V_1导联f波振幅与术后复发的关系[J].山东医药, 2016, 56(10):60-61.
[3] 张鸿雁, 李楠, 林敏. 孤立性房颤患者血浆 NT-proBNP、CRP及 D-二聚体水平变化及意义[J].山东医药, 2016, 56(24):68-70.
[4] Fukuda H, Lo B, Yamamoto Y,et al. Plasma D-dimer may predict poor functional outcomes through systemic complications after aneurysmal subarachnoid hemorrhage[J].J Neurosurg,2017, 127(2):284-290.
[5] 白中乐, 陶海龙, 邢军辉,等. NT-proBNP与左房容积变化对早期预测心房颤动射频消融后复发的分析[J].中国循证心血管医学杂志, 2017, 9(7):804-806.
[6] Regenold W T, Adler L, Blumenthal J B, et al. Poster number: NR 9 - Aβ42 plasma levels are increased in cognitively impaired individuals taking ACE inhibitor and ARB antihypertensives[J].Am J Geriatric Psychiatry,2016, 24(3):S141-S142.
[7] Leung AA, Nerenberg K, Daskalopoulou SS, et al. Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension[J].Can J Cardiol,2016, 32(5):589-597.
[8] 裴强, 王如兴, 李库林,等. 血浆基质金属蛋白酶2对心房颤动患者导管射频消融治疗术后复发的影响[J].临床心血管病杂志, 2016(1):44-46.
[9] 王建铭, 黄从新. 房颤射频消融术后的早期复发与晚期复发[J].中国心血管病研究, 2016, 14(5):385-388. |
2018, Vol. 35 
